Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.31B |
| 2 |
GSK
GSK
|
+$624M |
| 3 |
Meta Platforms (Facebook)
META
|
+$609M |
| 4 |
UnitedHealth
UNH
|
+$335M |
| 5 |
Microsoft
MSFT
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$611M |
| 2 |
Toronto Dominion Bank
TD
|
+$216M |
| 3 |
GE Aerospace
GE
|
+$195M |
| 4 |
CF Industries
CF
|
+$193M |
| 5 |
Mondelez International
MDLZ
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.73% |
| 2 | Energy | 8.89% |
| 3 | Industrials | 8.57% |
| 4 | Technology | 7.69% |
| 5 | Communication Services | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
iShares MSCI Germany ETF
EWG
$1.68B
| $8.03M | ﹤0.01% |
243,072
-94,098
| -28% | -$3.1M |
|
|
LBY
1727
DELISTED
Libbey, Inc.
LBY
| $8.01M | ﹤0.01% |
1,065,263
-178,899
| -14% | -$1.4M |
|
1728
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.42B
| $7.97M | ﹤0.01% |
130,352
+8,134
| +7% | +$486K |
|
1729
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.78B
| $7.97M | ﹤0.01% |
79,351
-142,048
| -64% | -$14.3M |
|
1730
ALPS Strategic Income Fund
RIGS
$60.6M
| $7.96M | ﹤0.01% |
316,628
+20,702
| +7% | +$524K |
|
1731
First Trust Exchange-Traded Fund VI Multi-Asset Diversified Income Index Fund
MDIV
$433M
| $7.96M | ﹤0.01% |
418,718
+117,907
| +39% | +$2.24M |
|
1732
PUT
AB InBev
BUD
$157B
| $7.92M | ﹤0.01% |
71,000
+1,000
| +1% | +$118K |
|
1733
Polaris
PII
$3.91B
| $7.91M | ﹤0.01% |
63,810
+6,794
| +12% | +$806K |
|
1734
CALL
BCE
BCE
$21.9B
| $7.9M | ﹤0.01% |
164,600
+134,600
| +449% | +$6.41M |
|
1735
Fortune Brands Innovations
FBIN
$5.69B
| $7.89M | ﹤0.01% |
134,876
-133,585
| -50% | -$7.59M |
|
1736
The Mosaic Company
MOS
$6.89B
| $7.88M | ﹤0.01% |
307,139
-1,311
| -0.4% | -$30.1K |
|
1737
PUT
Illumina
ILMN
$29B
| $7.87M | ﹤0.01% |
37,008
| – | – |
|
1738
State Street SPDR S&P International Dividend ETF
DWX
$529M
| $7.85M | ﹤0.01% |
190,569
-31,055
| -14% | -$1.26M |
|
1739
ProShares Ultra MidCap400
MVV
$166M
| $7.85M | ﹤0.01% |
191,379
+168,990
| +755% | +$6.59M |
|
1740
Edgewell Personal Care
EPC
$1.31B
| $7.83M | ﹤0.01% |
131,803
-8,404
| -6% | -$529K |
|
1741
iShares Global Healthcare ETF
IXJ
$4.2B
| $7.82M | ﹤0.01% |
138,962
-111,420
| -45% | -$6.27M |
|
1742
Nuveen Credit Strategies Income Fund
JQC
$708M
| $7.82M | ﹤0.01% |
950,630
-43,818
| -4% | -$362K |
|
1743
JetBlue
JBLU
$2.11B
| $7.81M | ﹤0.01% |
349,481
-543,982
| -61% | -$11.1M |
|
1744
CALL
Bristol-Myers Squibb
BMY
$131B
| $7.81M | ﹤0.01% |
127,400
-63,500
| -33% | -$3.97M |
|
1745
W.R. Berkley
WRB
$26.2B
| $7.78M | ﹤0.01% |
366,572
-9,879
| -3% | -$202K |
|
|
SNV
1746
DELISTED
Synovus
SNV
| $7.78M | ﹤0.01% |
162,274
-9,936
| -6% | -$471K |
|
|
PIV
1747
DELISTED
PWSHS S&P 500 HIGH QTY PORTF S&P HIGH QTY RKGS INDEX
PIV
| $7.72M | ﹤0.01% |
253,596
+12,782
| +5% | +$389K |
|
1748
Trinity Industries
TRN
$2.36B
| $7.72M | ﹤0.01% |
286,106
+37,376
| +15% | +$932K |
|
1749
First Trust Global Tactical Commodity Strategy Fund
FTGC
$3.09B
| $7.71M | ﹤0.01% |
372,061
+2,287
| +0.6% | +$46.8K |
|
|
PDLI
1750
DELISTED
PDL BioPharma, Inc.
PDLI
| $7.7M | ﹤0.01% |
2,810,842
-451,543
| -14% | -$1.39M |
|
Similar funds
Royal Bank of Canada's Q4 2017 Portfolio in Review
As of Q4 2017, Royal Bank of Canada held 7,447 positions worth $228B, up 9.4% from $208B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada deployed $9.66B of net new capital in Q4 2017, opening 331 new positions and adding to 2,461 existing holdings. Its largest new stake was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Energy and Industrials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $611M trimmed.
- Royal Bank of Canada's largest Q4 2017 buy was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.
- Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $2.31B increase.
- Royal Bank of Canada's biggest Q4 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $611M.
- Royal Bank of Canada fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $144M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $228B portfolio in Q4 2017.
- Royal Bank of Canada opened 331 new positions and closed 486 in Q4 2017.
- Royal Bank of Canada's portfolio value rose 9.4% quarter-over-quarter to $228B.
Based on Royal Bank of Canada's 13F filing for Q4 2017, filed 14 Feb 2018.